Dr. Azzi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 E 102nd St
New York, NY 10029Phone+1 212-241-6756
Education & Training
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2017
University of Balamand Faculty of MedicineClass of 2012
Certifications & Licensure
NY State Medical License 2017 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant Start of enrollment: 2023 Dec 11
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 3 citationsOverall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.Sanjal H Desai, Michael A Spinner, Andrew M Evens, Alice Sykorova, Veronika Bachanova
Blood Advances. 2023-12-12 - 61 citationsOutcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring IndexJoumana Kmeid, Jakapat Vanichanan, Dimpy P. Shah, Firas El Chaer, Jacques M. Azzi
Biology of Blood and Marrow Transplantation. 2016-03-01 - 25 citationsRisk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.Erik Vakil, Ajay Sheshadri, Saadia A. Faiz, Dimpy P. Shah, Yayuan Zhu
Transplant Infectious Disease. 2018-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
